Bectumomab
Bectumomab (IMMU-LL 2) is an humanized IgG2a mAb against human CD22 (antigen) . Bectumomab is also an anti-lymphoma antibody fragment. Bectumomab can be used for imaging in combination with technetium 99 (Tc99m LL2 Fab) . Moreover, Bectumomab examines in the staging of recurrent or newly diagnosed non-Hodgkin's lymphoma (NHL) and to assess targeting before radioimmunoresearch (RIT) [1].
Product Specifications
CAS Number
158318-63-9
Product Name Alternative
IMMU-LL 2
UNSPSC
12352203
Target
CD22
Type
Inhibitory Antibodies
Related Pathways
Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/bectumomab.html
Solubility
10 mM in DMSO
Smiles
[Bectumomab]
References & Citations
[1]Lamonica D, et al. Radioimmunoscintigraphy (RIS) with bectumomab (Tc99m labeled IMMU-LL2, Lymphoscan) in the assessment of recurrent non-Hodgkin's lymphoma (NHL) . Cancer Biother Radiopharm. 2002 Dec;17 (6) :689-97.
Shipping Conditions
Room temperature
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
P04-05500 500 mL
McCoy’s 5A Medium (modified), w: L-Glutamine, w: 2.2 g/L NaHCO3
Sign In for Pricing
View Details